Literature DB >> 33256053

Cognitive Conflict in Borderline Personality Disorder: A Study Protocol.

Victor Suarez1, Guillem Feixas1.   

Abstract

Borderline personality disorder (BPD) represents a severe mental condition that is usually characterized by distressing identity disturbances. Although most prevailing explanatory models and psychotherapy approaches consider and intervene on self-concept, they seem not to recognize or explore idiosyncratic cognitive conflicts that patients may experience. These conflicts, which have been conceptualized as "implicative dilemmas" and "dilemmatic constructs" by personal construct theorists, could be considered as key elements of the explanatory model for BPD to provide a better understanding of this disorder and possibly enhance the effectiveness of contemporary psychotherapeutic approaches. The current study (Identifier: NCT04498104) aims to examine the characteristics of the interpersonal cognitive system of a group of patients diagnosed with BPD, using the repertory grid technique, and to compare them with those of a community sample. We will test if BPD participants are more affected by cognitive conflicts than controls. Additionally, we will gauge the association between cognitive conflicts and symptom severity as well as their predictive capacity of treatment outcome. The obtained results will be a necessary step to determine if cognitive conflicts have a substantial role on the explanation of BPD. It could also help to consider the development of a conflict resolution intervention module for this disorder.

Entities:  

Keywords:  borderline personality disorder; cognitive conflict; dilemmatic construct; implicative dilemma; personal construct; predictors of outcome; repertory grid

Year:  2020        PMID: 33256053      PMCID: PMC7761325          DOI: 10.3390/bs10120180

Source DB:  PubMed          Journal:  Behav Sci (Basel)        ISSN: 2076-328X


  24 in total

Review 1.  Borderline personality disorder.

Authors:  Klaus Lieb; Mary C Zanarini; Christian Schmahl; Marsha M Linehan; Martin Bohus
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

Review 2.  Community and Clinical Epidemiology of Borderline Personality Disorder.

Authors:  William D Ellison; Lia K Rosenstein; Theresa A Morgan; Mark Zimmerman
Journal:  Psychiatr Clin North Am       Date:  2018-10-16

3.  Cognitive conflict resolution during psychotherapy: Its impact on depressive symptoms and psychological distress.

Authors:  Clara Paz; Adrián Montesano; David Winter; Guillem Feixas
Journal:  Psychother Res       Date:  2017-11-26

Review 4.  Suicidal behavior and aggression-related disorders.

Authors:  Michael S McCloskey; Brooke A Ammerman
Journal:  Curr Opin Psychol       Date:  2017-08-09

Review 5.  Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism.

Authors:  Vladan Starcevic; Aleksandar Janca
Journal:  Curr Opin Psychiatry       Date:  2018-01       Impact factor: 4.741

6.  Childhood abuse as a risk factor for suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Kevin G Lynch; Thomas M Kelly
Journal:  J Pers Disord       Date:  2002-06

7.  The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.

Authors:  P F Lovibond; S H Lovibond
Journal:  Behav Res Ther       Date:  1995-03

8.  Viewing Cognitive Conflicts as Dilemmas: Implications for Mental Health.

Authors:  Guillem Feixas; Luis Angel Saúl; Alejandro Avila-Espada
Journal:  J Constr Psychol       Date:  2009-02-18

Review 9.  Suicidality in Borderline Personality Disorder.

Authors:  Joel Paris
Journal:  Medicina (Kaunas)       Date:  2019-05-28       Impact factor: 2.430

10.  Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation - Outcome Measure.

Authors:  Adriana Trujillo; Guillem Feixas; Arturo Bados; Eugeni García-Grau; Marta Salla; Joan Carles Medina; Adrián Montesano; José Soriano; Leticia Medeiros-Ferreira; Josep Cañete; Sergi Corbella; Antoni Grau; Fernando Lana; Chris Evans
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.